News Daily News FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One L.A. McKeown June 19, 2019
News Daily News FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting L.A. McKeown June 10, 2019
News Conference News EuroPCR 2019 EFFPAC: Novel Paclitaxel DCB for PAD Demonstrates Efficacy With No Mortality Signal L.A. McKeown May 23, 2019
News Daily News ‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA L.A. McKeown February 20, 2019
News Daily News Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons L.A. McKeown February 19, 2019
News Daily News FDA Approves BioMimics 3D Stent for Femoropopliteal Artery Disease Caitlin E. Cox October 05, 2018
News Daily News No Benefits, Higher Costs With IVC Filters in Catheter-Directed Thrombolysis for DVT Michael O'Riordan July 23, 2018
News Conference News VIVA 2017 DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease L.A. McKeown September 13, 2017
News Conference News ISET 2017 Positive 6-Month Outcomes Seen With Endovascular Therapy for Symptomatic PAD: LIBERTY 360 Caitlin E. Cox February 07, 2017
News Industry News Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial February 21, 2016
News Daily News Drug-Eluting Balloon Continues to Show Positive Results in SFA, Popliteal Disease Jason Kahn September 15, 2011